CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.24 and traded as high as $0.24. CytoDyn shares last traded at $0.21, with a volume of 2,048,823 shares changing hands.
CytoDyn Price Performance
The company has a market capitalization of $282.23 million, a price-to-earnings ratio of -22.90 and a beta of 1.33. The business has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.18.
CytoDyn Company Profile
(
Get Free Report)
CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.
See Also
Before you consider CytoDyn, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CytoDyn wasn't on the list.
While CytoDyn currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
